跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈在新的选项卡/窗口中打开

Elsevier
通过我们出版

Series Editor

ACS

Antonella Chadha Santuccione

Chief Executive Officer

Antonella Chadha Santuccione, Ph.D. is a medical doctor with profound expertise in clinical pathology, neuroscience, and psychiatric disorders.

Currently, she works as a Global Medical Manager for Alzheimer’s disease at Roche Diagnostic. She is the Chief Executive Officer, Strategic Lead Officer, and cofounder at Women’s Brain Project. As a medical doctor, Antonella has decades of experience in preclinical research, patient treatment, clinical development, and setting up the international regulatory framework for Alzheimer’s disease. Always focused on solving the puzzles related to Alzheimer’s and other psychiatric diseases, she has worked with Swissmedic, the Bill and Melinda Gates Foundation, several European universities, the EU commission for Health and Food Safety, the World Health Organization, and several Alzheimer’s’ disease organizations. In 2018, Antonella was nominated in the TOP 100 Women in Business in Switzerland, and in 2019 she was nominated as one of the most prominent people in the city of Basel. Antonella is keenly interested in removing bias so that precision medicine and novel technologies can be delivered to patients in a more precise and timely manner. She is advocating and acting for the creation of an Institute for sex and gender precision medicine in Switzerland.